3649 results for «2370»
3649 results
New evidence for coronary revascularisation
21 May 2026 – From EuroPCR 2026
This session highlights new evidence in coronary revascularisation, including the role of CT-derived virtual stenting for procedural optimization, left ventricular unloading during complex PCI, long-term outcomes of FFR-guided PCI versus medical therapy, Impella CP support in high-risk PCI, and comparative results of PCI versus CABG in...
Spontaneous coronary artery dissection management with intracoronary imaging
22 May 2026 – From EuroPCR 2026
Explore the nuanced management of spontaneous coronary artery dissection (SCAD) with a focus on intracoronary imaging. This session examines diagnostic challenges, the limited role of coronary CT angiography, and strategies for managing occlusive SCAD cases, highlighting the evolving understanding of this complex condition.
TAVI in bicuspid - Planning to performance
22 May 2026 – From EuroPCR 2026
Dedicated to transcatheter aortic valve implantation (TAVI) in bicuspid aortic valves, this session examines anatomical assessment, sizing methods, and clinical outcomes. It includes meta-analyses and registry insights, addressing challenges such as stent deformation and leaflet modification to guide optimal TAVI performance in this distinct patient population.
Left main complications - Part 3
21 May 2026 – From EuroPCR 2026
This session reviews complex complications encountered in left main coronary interventions. It covers causes and management of acute left main occlusion, critical stenosis of coronary buttons, retrieval techniques for ostial stents, and strategies for managing challenging PCI scenarios that may precipitate or resolve catastrophic events.
Multivessel disease or left main disease
22 May 2026 – From EuroPCR 2026
This session explores revascularisation strategies for patients with multivessel or left main coronary artery disease. It emphasizes the role of intravascular physiology and imaging in guiding treatment decisions and highlights procedural factors that contribute to improved long-term clinical outcomes, supported by complex case discussions.
INOCA in patients with coronary artery disease
21 May 2026 – From EuroPCR 2026
This session focuses on ischaemia with non-obstructive coronary arteries (INOCA) in patients with coronary artery disease. It raises awareness of common clinical presentations, emphasizes accurate diagnosis through functional coronary testing, and discusses how tailored treatment strategies can improve patient outcomes in this frequently under-recognized condition.
Calcium in the coronary arteries - What could go wrong?
22 May 2026 – From EuroPCR 2026
This session delves into the complexities of treating calcified coronary artery lesions, highlighting strategic selection of PCI approaches, anticipation of potential complications, and agile adaptation of techniques to manage these challenges effectively. Featuring real-world cases from Ireland and the United Kingdom, it provides critical learnings on...
Challenges for TAVI in bicuspid
22 May 2026 – From EuroPCR 2026
This session addresses the unique challenges encountered during transcatheter aortic valve implantation (TAVI) in patients with bicuspid aortic valves. It covers procedural nuances for type 0 bicuspid valves, risks associated with anomalous coronary anatomy, and complex anatomical considerations such as large annulus and tortuous aorta, culminating...
Asymptomatic high-risk patients: can CT coronary angiography improve our practice?
21 May 2026 – From EuroPCR 2026
This session examines the role of cardiac computed tomography (CT) coronary angiography in improving clinical practice for asymptomatic high-risk patients. It discusses detection of vulnerable plaque features, the importance of inflammation and physiology in risk assessment, and explores individualized treatment pathways including PCI, medical therapy, or...
Beyond coronary arteries: SVG and peripheral interventions
22 May 2026 – From EuroPCR 2026
This session expands focus beyond coronary arteries to cover interventions in saphenous vein grafts (SVG) and peripheral arteries. It reviews long-term clinical outcomes of SVG PCI, real-world data from coronary artery bypass graft interventions, and advances in ultrasound-guided treatments of peripheral artery lesions, including predictors of...
Shock: enhancing our pathways of care
21 May 2026 – From EuroPCR 2026
This session explores advancements in the management pathways for patients experiencing cardiogenic shock, particularly those complicating STEMI. It discusses patient characteristics, timing of PCI procedures, updated SCAI shock staging, representation in clinical trials, and angiographic findings in shockable out-of-hospital cardiac arrest cases, aiming to enhance clinical...
Diversity in coronary artery disease treatment
22 May 2026 – From EuroPCR 2026
Focusing on the diversity in coronary artery disease treatment, this session highlights challenges ranging from maintaining interventional cardiology services during conflict to the influence of comorbidities such as type 2 diabetes mellitus on prognosis and risk assessment. It also presents clinical outcomes related to stent thrombosis...
Complex coronary artery intervention: how DCB can help us
21 May 2026 – From EuroPCR 2026
This session delves into the role of Drug-Coated Balloons (DCB) in managing complex coronary artery interventions. It covers DCB-based PCI approaches in challenging lesions, compares clinical outcomes between Paclitaxel-coated balloon-only PCI and other strategies, and evaluates the effectiveness of DCB versus Drug-Eluting Stents (DES) in de...
Combined mitral repair and LAA closure with two separate septal punctures - LIVE case
21 May 2026 – From EuroPCR 2026
A 79‑year‑old man with hypertension, a history of basal cell carcinoma and psoriasis, presented with symptomatic severe primary MR (flail P2 due to ruptured chordae) and bleeding complications (recurrent skin bleeding) while on DOAC therapy for permanent atrial fibrillation.
Two G5 MitraClip devices were implanted. Subsequently, through...
Complication management in CTO PCI - Part 2
22 May 2026 – From EuroPCR 2026
This session focuses on managing complications during chronic total occlusion (CTO) PCI procedures. It presents challenging cases including artery perforations, donor vessel-related procedural difficulties, and intramural hematoma rescue guided by intravascular ultrasound (IVUS). Strategies to address in-stent CTO and the unpredictable nature of CTO PCI complications...
A series of complex real-word challenges STEMI treatment from very different countries
21 May 2026 – From EuroPCR 2026
This session showcases a series of complex STEMI treatment challenges from diverse international settings, highlighting difficult coronary anatomies and complicated procedures. It discusses nuanced clinical scenarios where artery recanalisation does not always equate to reperfusion, and presents stepwise approaches to managing multivessel disease, renal failure, and...
Calcified lesion of distal protected left main - LIVE case
22 May 2026 – From EuroPCR 2026
An 85‑year‑old man with type 2 diabetes mellitus, hypertension, dyslipidemia, peripheral artery disease, COPD, and chronic kidney disease presented with CCS class II angina related to three‑vessel coronary artery disease. He had previously undergone hybrid revascularization, including PCI of the RCA ostium and CABG with LIMA...
Assessing coronaries in ACS with intracoronary imaging
21 May 2026 – From EuroPCR 2026
This session highlights the critical role of intracoronary imaging in evaluating acute coronary syndromes (ACS). It discusses the management of complex lesion morphologies involving calcium and thrombus, the diagnostic power of OCT in decision-making, challenges beyond angiography in right coronary artery pathology, and the identification of...
Learn from the experts: lifetime management for Evolut first redo TAVI (TAV-in-TAV) and explant
14 Feb 2026 – From PCR Tokyo Valves 2026
This session offers an in-depth exploration of lifetime management strategies for patients undergoing Evolut first redo TAVI procedures, including TAV-in-TAV and explant techniques. It provides a comprehensive understanding of clinical decision-making algorithms, technical challenges, and key considerations for successful procedural planning and execution, supported by real-world...
Real world outcomes and strategies for optimal TEER across diverse DMR anatomies
14 Feb 2026 – From PCR Tokyo Valves 2026
This session develops a nuanced understanding of the complexity inherent in DMR cases, informed by the latest registry data. It highlights the capabilities of the PASCAL device in managing challenging anatomies and achieving predictable clinical results, alongside contemporary strategies for device selection and optimal placement to...
